CELU
CELU
NASDAQ · Biotechnology

Celularity Inc-A

$1.32
-0.01 (-0.75%)
As of Apr 1, 3:46 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +840.9% upside
Low Target $7.12
Average Target $12.42
High Target $14.14
Current Price $1.32
Current
$1.32
Target
$12.42
$7.12 $12.42 avg $14.14
Scenario Analysis
Bear Case
$7.12
439.4%
Low target
Base Case
$12.42
+840.9%
Avg target
Bull Case
$14.14
+971.2%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$4.35
-69.7% from high
52-Week Low
$1.01
+30.7% from low
Target vs 52W High
$12.42
+185.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%